SEC Form D · filed December 30, 2025
Nacuity Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Charles M. Lieser · Fort Worth, TXExecDavid Wohlberg · Beverly Hills, CAExec · DirectorEmmett Cunningham, Jr · Fort Worth, TXDirectorHalden Conner · Fort Worth, TXExec · DirectorMartin Devenney · Milpitas, CAExecMichael Wall · San Diego, CAExecRobin Steele · Fort Worth, TXDirectorRusty Kelley · Fort Worth, TXDirectorGerald Cagle · Burlington, MADirectorJami Kern · Fort Worth, TXExecBenjamin Yerxa · Raleigh, NCDirectorDavid Rekhson · Chicago, ILExecMichael Wall · Fort Worth, TXExecRobin Steele · Fort Worth, TXDirectorDavid Wohlberg · Beverly Hills, CAExec · DirectorRusty Kelley · Fort Worth, TXDirectorGerald Cagle · FORT WORTH, TXDirectorJami Kern · Fort Worth, TXExecBenjamin Yerxa · Raleigh, NCDirectorEmmett Cunningham, Jr · Fort Worth, TXDirectorHalden Conner · Flower Mound, TXExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗